Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency

Journal of Lipid Research

Volumn 47, Issue 5, 2006, Pages 912-920

  Mezdour, Hafid ^a   Larigauderie, Guilhem ^b   Castro, Graciela ^b   Torpier, Gerard ^b   Fruchart, Jamila ^b   Nowak, Maxime ^b   Fruchart, Jean Charles ^b   Rouis, Mustapha ^b   Maeda, Nobuyo ^c  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSERM   (France)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

APOA1 C3 A4 gene cluster (human); apoa1 c3 a4 gene cluster (mouse); Atherosclerosis; High fat Western type diet; Hypoalphalipoproteinemia; Knockout mouse

Indexed keywords

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; APOLIPOPROTEINS C; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; DIETARY FATS; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MICE; RATS;

EID: 33646798747     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M500414-JLR200     Document Type: Article

References (42)

1. Miller, N. E., and A. R. Tall. 1992. High Density Lipoproteins and Atherosclerosis III. Excerpta Medica, Amsterdam.
2. Karathanasis, S. K. 1985. Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc. Natl. Acad. Sci. USA. 82: 6374-6378.
3. Pennacchio, L. A., M. Oliver, J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipoprotein influencing triglycerides in humans and mice by comparative sequencing. Science. 294: 169-173.
4. Sorci-Thomas, M., M. M. Prack, N. Dashti, F. Johnson, L. L. Rudel, and D. L. Williams. 1989. Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: relationship to plasma concentration of high density lipoproteins. J. Lipid Res. 30: 1397-1403.
5. Rothblat, G. H., F. H. Mahlberg, W. J. Johnson, and M. C. Phillips. 1992. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid Res. 33: 1091-1097.
6. Fielding, C. J., V. G. Shore, and P. E. Fielding. 1972. A protein co-factor of lecithin:cholesterol acyltransferase. Biochem. Biophys. Res. Commun. 46: 1493-1498.
7. Glomset, J. A. 1968. The plasma lecithin:cholesterol acyltransferase reaction. J. Lipid Res. 9: 155-167.
8. Utermann, G., and U. Beisiegel. 1979. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur. J. Biochem. 99: 333-343.
9. Steinmetz, A., R. Barbaras, N. Ghalim, V. Clavey, J. C. Fruchart, and G. Ailhaud. 1990. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor site. J. Biol. Chem. 265: 7859-7863.
10. Steinmetz, A., and G. Utermann. 1985. Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260: 2258-2264.
11. Karathanasis, S. K., E. Ferris, and I. A. Haddad. 1987. DNA inversion within the apolipoprotein AI/CIII/AIV-encoding gene cluster of certain patients with premature atherosclerosis. Proc. Natl. Acad. Sci. USA. 84: 7198-7202.
12. Ordovas, J. M., D. K. Cassidy, F. Civeira, C. L. Bisgaier, and E. J. Schaefer. 1989. Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11. J. Biol. Chem. 264: 16339-16342.
13. Yokota, H., Y. Hashimoto, S. Okubo, M. Yumoto, F. Mashige, M. Kawamura, M. Kotani, Y. Usuki, S. Shimada, K. Kitamura, et al. 2002. Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD. Atherosclerosis. 162: 399-407.
14. Li, H., R. L. Reddick, and N. Maeda. 1993. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice. Arterioscler. Thromb. 13: 1814-1821.
15. Maeda, N., H. Li, D. Lee, P. Oliver, S. H. Quarfordt, and J. Osada. 1994. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269: 23610-23616.
16. Weinstock, P. H., C. L. Bisgaier, T. Hayek, K. Aalto-Setala, E. Sehayek, L. Wu, P. Sheiffele, M. Merkel, A. D. Essenburg, and J. L. Breslow. 1997. Decreased cholesterol HDL levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. J. Lipid Res. 38: 1782-1794.
17. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353: 265-267.
18. Duverger, N., G. Tremp, J. M. Caillaud, F. Emmanuel, G. Castro, J. C. Fruchart, A. Steinmetz, and P. Denefle. 1996. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science. 273: 966-968.
19. Ebara, T., R. Ramakrishnan, G. Steiner, and N. S. Shachter. 1997. Chylomicronemia due to apolipoprotein C-III overexpression in apolipoprotein E-null mice. J. Clin. Invest. 99: 2672-2681.
20. Vergnes, L., N. Baroukh, M. A. Ostos, G. Castro, N. Duverger, M. N. Nanjee, J. Najib, J. C. Fruchart, N. Miller, M. Zakin, et al. 2000. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20: 2267-2274.
21. Williamson, R., D. Lee, J. Hagaman, and N. Maeda. 1992. Marked reduction of high-density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. USA. 89: 7134-7138.
22. nd edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
24. de la Llera-Moya, M., V. Atger, J. L. Paul, N. Fournier, N. Moatti, P. Giral, K. E. Friday, and G. H. Rothblat. 1994. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux: relationships between serum components and efflux, esterification and transfer. Arterioscler. Thromb. 14: 1056-1065.
25. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
26. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
27. Bisgaier, C. L., O. P. Sachdev, L. Megna, and R. M. Glickman. 1985. Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res. 26: 11-25.
28. Tall, A. R., P. Costet, and N. Wang. 2002. Regulation and mechanisms of macrophage cholesterol efflux. J. Clin. Invest. 110: 899-904.
29. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
30. Basu, S. K., J. L. Goldstein, and M. S. Brown. 1983. Independent pathways for secretion of cholesterol and apolipoprotein E by macrophages. Science. 219: 871-873.
31. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
32. Assmann, G., A. von Eckardstein, and H. B. Brewer. 1995. Familial HDL deficiency: Tangier disease. In The Metabolic Basis of Inherited Disease. C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle, editors. McGraw-Hill, New-York. 2053-2072.
33. Sakai, N., B. L. Vaisman, C. A. Koch, R. F. Hoyt, Jr., S. M. Meyn, G. D. Talley, J. A. Paiz, H. B. Brewer, Jr., and S. Santamarina-Fojo. 1997. Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency. J. Biol. Chem. 272: 7506-7510.
34. Orso, E., C. Broccardo, W. E. Kaminski, A. Bottcher, G. Liebisch, W. Drobnik, A. Gotz, O. Chambenoit, W. Diederich, T. Langmann, et al. 2000. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 24: 192-196.
35. McNeish, J., R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al. 2000. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc. Natl. Acad. Sci. USA. 97: 4245-4250.
36. Gao, J., Y. Wei, Y. Huang, D. Liu, G. Liu, M. Wu, L. Wu, Q. Zhang, Z. Zhang, R. Zhang, et al. 2005. The expression of intact and mutant human apoAI/CIII/AIV/AV gene cluster in transgenic mice. J. Biol. Chem. 280: 12559-12566.
37. Moore, R. E., M. A. Kawashiri, K. Kitajima, A. Secreto, J. S. Millar, D. Pratico, and D. J. Rader. 2003. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler. Thromb. Vasc. Biol. 23: 1914-1920.
38. Furbee, J. W., Jr., J. K. Sawyer, and J. S. Parks. 2002. Lecithin: cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice. J. Biol. Chem. 277: 3511-3519.
39. Aiello, R. J., D. Brees, P. A. Bourassa, L. Royer, S. Lindsey, T. Coskran, M. Haghpassand, and O. L. Francone. 2002. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler. Thromb. Vasc. Biol. 22: 630-637.
40. Watson, A. D., J. A. Berliner, S. Y. Hama, B. N. La Du, K. F. Faull, A. M. Fogelman, and M. Navab. 1995. Protective effect of high density lipoprotein associated paraoxonase: inhibition of the biological activity of minimally oxidised low density lipoproteins. J. Clin. Invest. 96: 2882-2891.
41. Hayek, T., J. Oiknine, G. Dankner, J. G. Brook, and M. Aviram. 1995. HDL apolipoprotein A-I attenuates oxidative modification of low density lipoprotein: studies in transgenic mice. Eur. J. Clin. Chem. Clin. Biochem. 33: 721-725.
42. Cockerill, G. W., J. Saklatvala, S. H. Ridley, H. Yarwood, N. E. Miller, B. Oral, S. Nithyanathan, G. Taylor, and D. O. Haskard. 1999. High-density lipoproteins differentially modulate cytokine-induced expression of E-selectin and cyclooxygenase-2. Arterioscler. Thromb. Vasc. Biol. 19: 910-917.